A Study in Myeloproliferative Disorders

NCT01134120 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Myeloproliferative Disorders
Thrombocythemia, Essential
Polycythemia Vera
Primary Myelofibrosis

Interventions

DRUG: LY2784544

Sponsor

Eli Lilly and Company